About us

Eclosion is a bridge between the academic and commercial worlds

The success of Eclosion is based on the unique combination of public, academic and private energies to transform academic excellence into breakthrough therapeutic products, economic value and jobs. Eclosion leverages the strengths of the Lake Geneva region, continental Europe's #1 biotech cluster, into a hands-on test platform where breakthrough innovations can achieve an industrial proof-of-principle and, when successful, be launched as new companies with innovative products providing new solutions to large unmet medical needs.

This ability to federate public, academic and private energies beyond cantonal and national borders is based on all partners being convinced that the transformation of knowledge into therapeutic products, economic value and jobs is key for the future of the region at large. Today, all partners have witnessed the effectiveness of Eclosion's model, and are committed to continue this fruitful partnership.

Eclosion has a track record of successes

• Four companies launched and funded as the result of Eclosion's hands-on selection process.
• Three Companies entered clinical phase 1 in 2011
• Successful 2nd round co-fundings of portfolio companies with prestigious Industrial and Financial Partners.
• Renewed confidence from the State, Academic Institutions and Industrial Partners, confirming their continued support of Eclosion's successful public - private partnership.

Eclosion capitalizes on the most dynamic life science region in Europe

• An exceptional immediate environment of 12'500 life science scientists from Lake Geneva and Rhône-Alpes Academic Institutions, one of the leading bio-clusters in the world.
• Eclosion's reputation increasingly attracts projects from the rest of Europe, totaling hundreds of academic innovations seeking to enter the Eclosion process.
• more than 15 projects under buildup at Eclosion's state of the art facilities.